June 23, 2024

Common Cholesterol-Lowering Drug Found to Slow Vision Loss in Diabetes Patients

ORLANDO, Fla., June 21, 2024. Today, findings from the Lowering Events in Non-proliferative retinopathy in Scotland (LENS) Trial revealed that

Just 1 Year Of This Exercise Could Preserve Leg Strength In Retirees, Study Reveals

Great news for those concerned about maintaining health post-retirement. While mental relaxation and a healthy lifestyle are all important during

Expert consensus and guidance for integrating discussions of racism in pediatric care

Extensive research shows the link between exposure to racism during childhood and adolescence and increased risks of depression and metabolic

Trial Points to Best Practices for Inhaled Insulin in Type 1 Diabetes

ORLANDO — For type 1 diabetes patients, switching from an insulin pump or multiple daily injections to inhaled insulin (Afrezza)

Trial: Fenofibrate Slows Diabetic Retinopathy Progression

ORLANDO, Fla. — The old, generic cholesterol drug fenofibrate has shown potential for slowing the progression of diabetic retinopathy in

Depression During Pregnancy, Post-Delivery Raises Heart Disease Risk: Study

Having depression during pregnancy or after giving birth raises heart disease risk in women, a new study revealed. Researchers noted

Continuous Glucose Monitoring Can Aid Hospital Patients

ORLANDO, FL — Continuous glucose monitoring (CGM) of hospitalized patients with diabetes could provide early and important clues about changing

FDA OKs first menthol e-cigarettes, citing potential to help adult smokers

In this article MO Follow your favorite stocksCREATE FREE ACCOUNT NJOY Ace Source: NJOY The Food and Drug Administration on

-